UCB SA - Company Profile
Powered by 
All the data and insights you need on UCB SA in one report.
$295
- Save hours of research time and resources with
our up-to-date UCB SA Strategy Report
- Understand UCB SA position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
View up-to-date information on UCB SA patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| UA126295C2 | Grant | ANTI-ALPHA-SYNUCLEIN ANTIBODIES | A61K2039/505; A61P25/16; C07K16/18; C07K2317/24; C07K2317/33; C07K2317/34; C07K2317/51; C07K2317/515; C07K2317/55; C07K2317/56; C07K2317/565; C07K2317/567; C07K2317/76; C07K2317/92; C07K2317/94; G01N2800/2835; G01N33/6896 | September 14, 2022 |
| CN115052900A | Application | 抗KLK5抗体 | A61P17/00; A61P35/00; C07K16/40; C07K2317/24; C07K2317/34; C07K2317/76; C07K2317/92; C07K2317/94 | September 13, 2022 |
| JP2022539538A | Application | ＩＬ－１７調節剤としての縮合イミダゾール誘導体 | A61K31/4245; A61K31/4353; A61K31/4439; A61K31/497; A61K31/501; A61K31/519; A61K45/06; A61P29/00; A61P37/00; C07D403/14; C07D405/14; C07D413/14; C07D417/14; C07D487/04; C07D498/04 | September 12, 2022 |
| CN115038722A | Application | 针对KLK5的抗体 | A61P17/00; A61P35/00; C07K16/40; C07K2317/24; C07K2317/34; C07K2317/76; C07K2317/92; C07K2317/94 | September 09, 2022 |
| US20220280887A1 | Application | METHODS FOR PURIFYING ANTIBODIES | B01D15/3809; C07K1/18; C07K1/22; C07K16/065; C07K16/12 | September 08, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward